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The threat of West Nile virus (WNV) epidemics necessitates the development of a technology platform that can produce reagents
to support detection and diagnosis rapidly and inexpensively. A plant expression system is attractive for protein production due to
its low-cost and high-scalability nature and its ability to make appropriate posttranslational modiﬁcations. Here, we investigated
the feasibility of using plants to produce two WNV detection and diagnostic reagents to address the current cost and scalability
issues. We demonstrated that WNV DIII antigen and E16 monoclonal antibody are rapidly produced at high levels in two plant
species and are easily puriﬁed. Furthermore, they are eﬀective in identifying WNV and in detecting human IgM response to WNV
infection.E16mAbdoesnotcross-reactwithotherﬂaviviruses,therefore,isvaluableforimprovingdiagnosticaccuracy.Thisstudy
provides a proof of principle for using plants as a robust and economical system to produce diagnostic reagents for arboviruses.
1.Introduction
West Nile virus (WNV) is an arbovirus that belongs to the
FlavivirusgenusoftheFlaviviridaefamily.Itisaneurotropic,
enveloped virus with a single-stranded, positive polarity, 11
kilobase RNA genome. The transmission cycles of WNV
involve mosquitoes of the genus Culex and birds, while
humans and other mammals are incidental hosts. Until
1999, WNV was found in the Eastern Hemisphere, with
wide distribution in Africa, Asia, the Middle East, and
Europe [1]. In 1999, WNV entered the Western Hemisphere
through New York City. Since then, more than 30,000
humans with severe WNV infection in the continental
United States have been diagnosed, with many more cases
of infection remaining undiagnosed. Advanced age is one of
the greatest risk factors for severe neurological disease, long-
term morbidity, and death [2], although a genetic basis of
susceptibility has also been recently identiﬁed [3].
Several methods have been developed for the detection
of WNV and WNV infections. Speciﬁc work in mosquito
vectors and infected avian or mammalian hosts has been
successful and is protein or nucleic acid based [4–6]. Human
WNV infection can be diagnosed by detecting host immune
responses such as WNV-speciﬁc IgM or IgG production
with enzyme-linked immunosorbent assays (ELISAs) or
by directly identifying WNV from cell cultures of serum,
cerebrospinal ﬂuid, or tissues with WNV-speciﬁc mono-
clonal antibodies (mAbs) [4, 7, 8]. Reverse-transcriptase
polymerase-chain-reaction- (RT-PCR-) based assays have
also been developed to identify the presence of the RNA
genomeofWNV[9,10].Bothproteinandnucleicacid-based
assaysarebeingevaluatedforidentifyingWNVoritsgenome
in other mammals, mosquito pools, and avian specimens.
However, due to the short viremic phase and low viral count
of WNV in human blood and cerebrospinal ﬂuid, protein-
based assays such as ELISA have increasingly become the
standard methods of detection and diagnosis [7]. Currently,
WNV-speciﬁc mAbs, recombinant WNV antigens, and other
protein-based detecting reagents are produced in mouse
hybridoma, mammalian, insect, or bacterial cell cultures
[11–13]. The high production costs and limited scalability
associated with the bioreactor-based cell culture system may
limit their application. The expanding epidemics of WNV
demand the development of a technology platform that can
rapidly produce reagents to accommodate the detection and
diagnostic needs at a low cost.2 Journal of Biomedicine and Biotechnology
Plantshavebeenproposed asbioreactorsforproteinpro-
duction because of their capacity to generate large volumes
of proteins at low cost and their ability to make appropriate
posttranslational modiﬁcation of recombinant proteins [14,
15]. Traditionally, proteins are produced in transgenic plants
that require an extensive time period to generate transgenic
lines [16]. In contrast, transient expression of a target
gene in plant material can produce the target protein
within 1 to 2 weeks [17]. The recently developed transient
expression systems based on plant viral vectors promote
high-level accumulation of foreign protein due to their
eﬃcient replication, which results in high copy numbers of
transgenes and their mRNA transcripts [18, 19]. An example
of a viral-based vector uses tobacco mosaic virus (TMV) and
potato virus X (PVX) genomes under the control of plant
promoters (the MagnICON system) [20]. Another example
is the geminivirus-based expression system: a DNA replicon
system derived from the bean yellow dwarf virus (BeYDV)
that allows rapid high-yield production of proteins in plants
[21]. These plant-based transient expression systems provide
the speed and ﬂexibility of bacterial gene expression system
coupled with the posttranslational protein modiﬁcation
capability and yield of mammalian cell cultures.
In this study, we demonstrate the feasibility of using
plant transient expression systems to produce two groups
of protein reagents that are required for the detection and
diagnosis of WNV infection: a recombinant antigen derived
from the domain III (DIII) of WNV envelope (E) protein
and a mAb (E16) that speciﬁcally recognizes WNV DIII.
Our plant transient expression systems permit high-level
expression of WNV DIII antigen and E16 mAb in both Ni-
cotiana benthamiana and lettuce plants. These detection and
diagnostic reagentscanbeeasilypuriﬁedtogreaterthan95%
purity. In addition, our results demonstrate their functional
activity and utility in identifying WNV and in detecting hu-
man IgM response to WNV infections. Therefore, this study
providesproofofprincipleforusingplantsasarobust,rapid,
and ﬂexible production system for protein reagents for the
detection and diagnosis of WNV and can be broadly applied
to other arboviruses.
2.MaterialsandMethods
2.1. Experimental Materials. The DIII protein of Dengue
virus serotype 2 (DENV-2) was purchased from Genway
Biotech (San Diego, Calif, USA). The E. coli-produced DIII
protein of WNV was a gift from Dr. M. Diamond (Wash-
ington University School of Medicine, St. Louis, Mo, USA).
The West Nile IgM capture ELISA kit was obtained from
Diagnostic Automation Inc. (Calabasas, Calif, USA).
2.2.ConstructionofPlantExpressionVectors. Thecodingseq-
uence of WNV E protein DIII 13.5kDa ectodomain (amino
acids 296–415 of WNV E protein of the New York 1999
strain, Genbank Accession number AF196835) was opti-
mized in silico with N. benthamiana-optimized codons using
an algorithm as described in Villalobos et al. [22]. An 18-
bp sequence coding for a hexahistidine (His6) puriﬁca-
tion tag was added to the C-terminus of the DIII gene. Opti-
mized DIII-His6 sequence was synthesized (DNA 2.0, Menlo
Park, Calif, USA) and cloned into the 5  modules of plant
expression vector pICH11599 of the MagnICON system
as described previously [20]. The geminiviral vector pBY-
HL(hE16-no-KDEL).R for expressing E16, a mAb against
WNV E protein [13, 23], was constructed by replacing
the E16 heavy chain (HC)-KDEL sequence in vector pBY-
HL(hE16).R [24] with the KDEL-less E16 HC sequence.
The expression of the resulting pBY-HL(hE16-no-KDEL).R
vector produces E16 mAb molecules in which the C-termini
of the HC are not attached by the ER-retention signal KDEL.
2.3. Agroinﬁltration of N. benthamiana and Lettuce. Plant
expression vectors were individually transformed into Agro-
bacterium tumefaciens GV3101 by electroporation as pre-
viously described [25]. Wild-type N. benthamiana and
lettuce (L. sativa) plants were grown in a greenhouse with
16/8hr light/dark cycle at 25◦C for 6 weeks. For DIII
expression N. benthamiana leaves were co-agroinﬁltrated
with GV3101 strains containing the DIII 5  module along
with the TMV 3  module, and an integrase construct, with
a syringe as described previously [26]. For E16 expression
in N. benthamiana, the syringe-agroinﬁltration method was
also used to deliver the geminiviral vector pBY-HL(hE16-
no-KDEL).R into leaves. Lettuce heads were inﬁltrated
with the GV3101 strain containing the geminiviral vector
pBY-HL(hE16-no-KDEL).R for 2 × 5min under vacuum
(100mbar) as described previously [27].
2.4. Extraction of Total Protein from Plant Leaves. Agroinﬁl-
trated N. benthamiana or lettuce leaves were harvested 3–8
days following inﬁltration (dpi) for evaluating the temporal
pattern of DIII and E16 mAb expression. For other protein
analysis, plant leaves were harvested 4dpi. Total leaf protein
was extracted by homogenization in extraction buﬀer I
(100mM Tris-HCl, pH 8.0, 150mM NaCl, 1mM phenyl-
methylsufonyl ﬂouride) for DIII antigen or extraction buﬀer
II (PBS, pH 7.4, 1mM EDTA, 10mg/mL sodium ascor-
bate, 10μg/mL leupeptin, 0.3mg/mL phenylmethylsufonyl
ﬂouride) for E16 mAb using a FastPrep machine (Qbiogene,
Carlsbad, Calif, USA) following manufacturers instructions.
Extraction buﬀers I and II were speciﬁcally developed based
on the biochemical properties of DIII antigen and E16
mAb for the maximal extraction and stability of each target
protein, while minimizing the coextraction of plant host
proteins. The crude plant extract was clariﬁed by centrifu-
gation at 18,000 ×gf o r3 0m i na t4 ◦C. The concentration of
leaf total soluble protein (TSP) was measured by using the
Protein Bradford Assay (Hercules, Calif, USA).
2.5. SDS-PAGE and Western Blot Analysis. SDS-PAGE and
western blotting were performed as described previously
[28].Proteinsamplesweresubjectedto12%or4–20%gradi-
ent SDS-PAGE under reducing (5% v/v β-mercaptoethanol)
or nonreducing conditions. Gels were then either stained
with Coomassie blue or used to transfer proteins onto PVDF
membranes. Horseradish-peroxidase- (HRP-) conjugatedJournal of Biomedicine and Biotechnology 3
antibodies against human-kappa light chain (LC) or gamma
heavy chain (HC) (Southern Biotech, Birmingham, Ala,
USA) were used for western blot analysis of E16 mAb. For
DIII antigen, a rabbit anti-WNV DIII polyclonal antibody
and an HRP-conjugated goat anti-rabbit IgG (Southern
Biotech, Birmingham, Ala, USA) were used for the analysis.
2.6. Puriﬁcation of DIII Antigen and E16 mAbs from Plant
Tissue. N. benthamiana or lettuce leaves were harvested on
4dpi and extracted with a blender in extraction buﬀer I
(for DIII) or extraction buﬀer II (for E16), and the extract
was clariﬁed by ﬁltering through Miracloth, followed by
centrifugation at 17,700 ×gf o r3 0 m i na t4 ◦C. For DIII
puriﬁcation, the pH of the clariﬁed extract was adjusted
to pH 5.0 and followed by centrifugation at 17,700 × g
for 30min at 4◦C to precipitate the most abundant plant
protein, the photosynthetic enzyme RuBisCo, and other host
proteins. The supernatant was adjusted to pH 8.0 and respun
to remove residue precipitates. The supernatant was then
applied to a Ni-NTA His-Bind column and puriﬁed by metal
chelation chromatography according to a protocol supplied
by the manufacturer (Novagen, Madison, Wis, USA). The
column eluate containing the puriﬁed DIII antigen was
buﬀer-exchanged to PBS. For E16 puriﬁcation, the clariﬁed
leaf extract was ﬁltered through a 0.2-micron ﬁlter and
loaded directly to a MAbSelect Protein A column (GE
Healthcare, Piscataway, NJ, USA). The column was eluted
with 50mM sodium citrate, pH 2.5. Tris-base (1M) was
added immediately to the eluate to attain a ﬁnal pH of 7.0.
The purity of DIII or E16 was determined by quantitating
Coomassie blue—stained protein bands on SDS-PAGE using
a densitometer as described previously [26].
2.7. ELISA. E16 quantitative ELISA was designed to detect
the assembled form of E16 mAb (with both LC and HC)
as described previously [23]. Plates were coated with a goat
anti-human-gamma HC antibody (1:2,000 dilution, South-
ern Biotech, Birmingham, Ala, USA). After incubation with
plantproteinextract,anHRP-conjugatedanti-human-kappa
LC antibody (1:10,000 dilution) was used as the detection
antibody. A mammalian cell-culture-derived E16 was used
as a reference standard [13] .T h ep l a t e sw e r ed e v e l o p e dw i t h
3,3 ,5,5 -tetramethylbenzidine (TMB) substrate (KPL Inc,
Gaithersburg, Md, USA).
DIII expression analysis was performed by coating plates
with a monoclonal mAb against WNV DIII (1:2,000 dil-
ution) [13]. Clariﬁed plant extract was then applied to the
wells followed by detection with a rabbit anti-WNV DIII
antibody (1:10,000 dilution) and an HRP-conjugated goat
anti-rabbit IgG antibody (1:10,000 dilution).
Binding speciﬁcity of plant-derived E16 to DIII protein
of various ﬂaviviruses was performed using a previous
published method [29]. An E. coli-derived WNV DIII [29]
or DENV-2 DIII (100uL, 2ug/mL) was immobilized on
microtiterplates.AnHRP-conjugatedanti-human-kappaLC
antibody (1:10,000 dilution) was used as the detection anti-
body. A mammalian cell-culture-derived E16 and a generic
humanIgG(SouthernBiotech, Birmingham, Ala,USA)were
used as the positive and negative control, respectively.
The WNV IgM capture ELISA was performed according
to the procedures provided by the manufacturer (Diagnostic
Automation Inc. Calabasas, Calif, USA). Brieﬂy, E16 mAbs
derived from N. benthamiana and lettuce were conjugated
to HRP with a commercial Lightning-Link HRP conjugation
kit (Innova Biosciences, Cambridge, UK). Human WNV
IgM positive control (PC) or negative control (NC) serum
was incubated in microtiter wells coated with anti-human
IgM antibodies. This was followed by incubation with
a negative control antigen (NCA), a kit-supplied WNV
recombinant antigen protein (WNRA), or plant-derived
WNV DIII antigen (50uL, 1:25 dilution). After washing,
wells were incubated with either a kit-supplied WNRA-
speciﬁc antibody (anti-WNRA) labeled with HRP or
with the HRP-conjugated plant-derived E16 (50uL, 1:100
dilution).Highconcentrationsofplant-derivedDIIIandE16
mAb were used to saturate their respective target-binding
sites, ensuring all WNV-speciﬁc IgM molecules captured on
the plate are detected. After further washing, TMB substrate
was used to develop the plate. The Immune Status Ratio
(ISR) is calculated by dividing the average absorbance of
the WNRA or plant-derived DIII antigen by the average
absorbance of NCA (WNRA/NCA or Plant DIII/NCA). The
quality control speciﬁcations for this ELISA are PC ISR >
5.66 and NC ISR < 4.47.
2.8. Flow Cytometry of Yeast Displaying WNV E Protein.
Analysis of the detection of WNV E protein by plant-derived
E16 was performed using a yeast strain that expresses WNV
E protein on its surface. The staining of yeast cells and ﬂow
cytometry analysis were performed as described previously
[13]. Brieﬂy, yeast cells were grown to log phase, followed
by an additional 24h in tryptophan-free media containing
2% galactose to induce WNV E protein expression. The yeast
cells were then incubated with E16 mAbs derived from N.
benthamiana or lettuce. A generic human IgG was used as
a negative control mAb. The yeast cells were stained with
a goat anti-human secondary antibody conjugated to Alexa
Fluor 488 (Invitrogen, Carlsbad, Calif, USA). Subsequently,
the yeast cells were analyzed on a BD FACSCalibur ﬂow
cytometer (Franklin Lakes, NJ, USA).
3. Results
3.1. Expression of WNV DIII Recombinant Antigen with
Transient Expression Vectors in N. benthamiana Plants. As
an initial test of the feasibility of using plant to produce
WNVdiagnosticreagent,weexaminedtheexpressionofDIII
antigen in the plant host of N. benthamiana.T h i si sap l a n t
species that is related to the common tobacco plants and
hasbeenusedextensivelyinproducingrecombinantproteins
[30]. Western blot analysis showed that DIII antigen was
detected in the plant sample inﬁltrated with DIII construct
with the expected molecular weights of 13.5kDa along with
an E. coli-produced DIII positive control (Figure 1(a)). This
band was not detected in negative control leaf samples
that were inﬁltrated with inﬁltration buﬀer, conﬁrming the
speciﬁcityoftheDIIIband(Figure 1(a)).Theslightlysmaller
molecular weight of plant-derived DIII reﬂects the fact that4 Journal of Biomedicine and Biotechnology
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Figure 1: Western blot analysis of WNV DIII antigen and E16 mAb expression in N. benthamiana and lettuce. (a) WNV DIII. Leaf protein
extracts were separated on a 4–20% SDS-PAGE gradient gel and transferred onto PVDF membranes. The membranes were probed with a
rabbit anti-WNV DIII polyclonal antibody. Lane 1: E. coli-derived DIII standard; lane 2: protein extract from leaves inﬁltrated with buﬀer
(negativecontrol);lane3:extractfromDIIIconstructinﬁltratedN.benthamianaleaves.(b)and(c)ExpressionofE16.Wild-typelaboratory-
grown lettuce or N. benthamiana were inﬁltrated with dual-replicon geminiviral vector pBY-HL (hE16-no-KDEL). R and harvested on
4dpi. Total leaf protein extracts were separated on 4–20% SDS-PAGE gradient gels under reducing conditions and transferred to PVDF
membranes. The membranes were incubated with a goat anti-human-gamma chain antibody to detect HC (b) or a goat anti-human-kappa
chain antibody to detect LC (c). Lane 1: human IgG reference standard; lane 2: extract from lettuce leaves inﬁltrated with buﬀer (lettuce
negative control); lane 3: protein samples from lettuce inﬁltrated with geminiviral vector pBY-HL(hE16-no-KDEL). R; lane 4: extract from
buﬀer-inﬁltrated N. benthamiana leaves (negative control); Lane 5: N. benthamiana leaf protein extract inﬁltrated with pBY-HL(hE16-no-
KDEL). R vector.
it lacks the extra N-terminal peptide tags (His-Tag and T7-
Tag) in the E. coli-derived DIII. Western blot conﬁrmed the
stability of plant-derived DIII as only the expected band
was observed. The production of DIII was conﬁrmed by a
sandwich ELISA using two WNV speciﬁc antibodies. ELISA
resultsalsoindicatedthatDIIIreachedahighexpressionlevel
within 4 days after inﬁltration, with an average accumulation
of 1% TSP (Figure 2), which corresponds to ∼0.1mg/g
fresh leaf weight (FLW). This level is comparable to the
high range of accumulation of other antigens in plants [25]
and is the highest expression level of any ﬂavivirus antigen
ever reported in plants. This convincingly demonstrates
that plants can rapidly express DIII antigen at high levels.
Furthermore, in contrast to E. coli-produced DIII which
requires a cumbersome solubilization and refolding process
[11], plant-derived DIII is produced as a soluble protein and
can be easily puriﬁed to greater than 95% purity (data not
shown) by a metal chelation chromatography.
3.2. High-Level Expression and Assembly of a mAb against
WNVinWild-TypePlants. Tofurtherdemonstratetheutility
of plants as a platform for production of protein reagents,
we examined the production of a mAb, a representative
of another important group of relevant molecules used in
the detection and diagnosis of WNV infection. To compare
the expression of E16 mAb in two species of plant hosts
(N. benthamiana and lettuce), we used the BeYDV-based
geminiviral replicon vectors. In contrast to the MagnICON
system, these vectors have been shown to direct transgenic
protein expression in both tobacco and lettuce [24]. The
Agrobacterium strain containing replicons of the LC- and
HC-codingsequencesofE16wereinﬁltratedintolaboratory-
grown lettuce and N. benthamiana leaves. Western blot
analysis revealed that the LC and HC of E16 were expressed
in both lettuce and N. benthamiana leaves with the expected
molecular weights of 25kDa and 50kDa, respectively, (Fig-
ures 1(b) and 1(c)) .T h ef u l lt e t r a m e r i c( 2 H C+2 L C )
assembly of these mAbs was demonstrated by western blot
(data not shown) and Coomassie blue staining analysis
(Figure 3, Lanes 5–7) under nonreducing conditions. The
assembly of pHu-E16 was corroborated by an ELISA that
detects the assembled form of E16 (HC capture, LC probe,
Figure 2). Since only the expected bands were observed on
western blots, the results established that E16 is stable during
biosynthesis in both plant hosts and proteolytic degradation
of the LC or HC did not occur. Further ELISA analysis also
showed that E16 was produced rapidly in both plant species
and reached a high level of accumulation to 3.5% (in lettuce)
or 5% TSP (in N. benthamiana) on 4dpi (Figure 2). This
expression level is comparable to the highest expression level
of mAbs reported by geminiviral vectors in both lettuce and
tobacco [24]a n db yM a g n I C O Nv e c t o r si nt o b a c c o[ 26].
Overall, these results demonstrate that fully assembled E16
mAb can be produced rapidly at high levels in both lettuce
and N. benthamiana plant hosts.
3.3. Puriﬁcation of E16 mAbs from Plant Tissue. To examine
whether plant-derived E16 mAbs can be recovered from
plant tissue eﬀectively, we extracted and puriﬁed the mAbs
from inﬁltrated lettuce and N. benthamiana leaves using an
aﬃnity chromatography method based on Protein A resin.
Coomassie blue staining analysis of SDS-PAGE showed that
E16 mAbs produced in lettuce and N. benthamiana can
be puriﬁed to >95% purity with intact HC and LC using
this single-aﬃnity chromatography step (Figure 3). A similar
analysisundernonreducingconditionsconﬁrmedthatmAbsJournal of Biomedicine and Biotechnology 5
B-DIII L-E16 B-E16
0
1
2
3
4
5
6
T
S
P
(
%
)
Figure 2: Accumulation of WNV DIII antigen and E16 mAbs in N.
benthamianaandlettuce.Totalproteinsfromplantleavesinﬁltrated
with DIII or E16 expression vectors were extracted on 4dpi and
analyzed by ELISA with E. coli-produced WNV DIII or mammalian
cell-produced E16 as the reference standard. For DIII ELISA, a
monoclonal mAb against WNV DIII [13] was the capture antibody,
and a rabbit anti-WNV DIII antibody was the detection antibody.
For E16, goat anti-human gamma- and kappa-chain antibodies
were used as capture and detection reagents, respectively, to detect
the assembled form of E16 mAb. Mean ± SD of samples from
three independent inﬁltrations are presented. B-DIII: WNV DIII
produced in N. benthamiana; L-E16: lettuce-produced E16; B-E16:
N. benthamiana-derived E16.
produced in both plant hosts remained fully assembled after
puriﬁcation(Figure 3lanes5–7).Theseresultsdemonstrated
that E16 mAb not only can be rapidly produced at high levels
in twohost plant species butalsocan be isolated and puriﬁed
to high purity using a facile puriﬁcation method.
3.4. Plant-Derived DIII WNV Antigen and mAbs Are Func-
tional in Detection and Diagnosis of WNV Infection. Func-
tional characterizations were performed to determine if
DIII antigen and E16 mAbs produced in plants retained
their biological activities and can be used in detection and
diagnosisassaysforWNVinfection.AsshowninFigures1(a)
and 2, plant-derived DIII antigen retains the ability to bind
antibodies thatspeciﬁcallyrecognize DIIIofWNVEprotein.
This binding speciﬁcity was conﬁrmed by the lack of binding
of plant-derived DIII to other non-DIII-speciﬁc mAbs (data
not shown).
One of the issues facing the current immunobased WNV
diagnosis is the cross-reactivity of antibodies against WNV
with other ﬂaviviruses. The E16 mAb produced from mam-
malian cells binds to a speciﬁc region of WNV DIII and
does not cross-react with DIII of other ﬂaviviruses [13].
To examine the binding speciﬁcity of plant-derived E16,
various concentrations of this mAb were incubated with
eitherDIIIofWNVorDIIIofDENV-2thatwasimmobilized
250
150
100
75
50
37
25
1234567
(
k
D
a
)
Figure 3: Puriﬁcation of E16 mAbs produced in lettuce or N.
benthamiana. Puriﬁed E16 mAbs were analyzed on a 12% SDS-
PAGE gel using either reducing (Lanes 2–4) or nonreducing (Lanes
5–7) sample buﬀer. Lane 1: Molecular weight marker; lanes 2 and
5: mammalian cell-derived E16 as reference standard; lanes 3 and
6: E16 puriﬁed from lettuce leaves; lanes 4 and 7: puriﬁed E16
from N. benthamiana. One representative of several independent
experiments is shown.
on an ELISA plate. As shown in Figure 4, the binding to
WNV DIII increased with the concentration of lettuce or
N. benthamiana-derived E16 in the reaction in a similar
manner as the mammalian cell-derived E16 positive control.
In contrast, none of the E16s showed speciﬁc binding to
DIII of DENV-2 (Figure 4). The negative control IgG (a
generic human IgG) showed no speciﬁc binding to either
WNV or DENV-2 DIII (Figure 4). These results indicate that
the speciﬁc avidity for WNV DIII is retained by the plant-
derivedE16s.Thishighspeciﬁcitymakesitavaluablereagent
in obtaining unambiguous diagnostic results for detecting
WNV and WNV infection.
We ﬁrst examined the application of plant-derived E16
mAbs in detecting the presence of WNV antigens by using
a ﬂow cytometry assay. In this assay, WNV E protein is
displayed on the surface of yeast, and the ability of mAbs in
detecting WMV E protein is measured by ﬂow cytometry
[13]. Our analysis showed that the percentage of yeast cells
expressing WNV E protein and the mean ﬂuorescence inten-
sity of binding by lettuce or N. benthamiana-derived E16
were signiﬁcantly higher compared to the negative control
antibodies(Figure 5).Thisresultindicatesthatplant-derived
E16s are eﬀective in speciﬁcally detecting WNV proteins.
We further demonstrated the utility of plant-derived WNV
DIII antigen and E16 mAb in a WNV IgM capture ELISA as
another example of their potential application as diagnostic
reagents. In the original commercial kit for diagnosis of
WNV infection, controls and serum samples are incubated
in microtiter wells which have been coated with anti-human
IgM antibodies. The microtiter wells are then incubated
with WNV recombinant antigen (WNRA) or a negative
control antigen (NCA) and followed by incubation with
WNRA-speciﬁc antibody labeled with HRP. The presence
of IgMs against WNV is determined by whether the ratio of6 Journal of Biomedicine and Biotechnology
Antibody concentration (ng/mL)
0
0.2
0.4
0.6
0.8
1
WNV DIII: M-E16
WNV DIII: L-E16
WNV DIII: B-E16
WNV DIII: NC
DENV-2 DIII: L-E16
DENV-2 DIII: B-E16
DENV-2 DIII: NC
0 500 1000 1500 2000
O
D
4
5
0
Figure 4: Highly speciﬁc binding of plant-derived E16 to WNV
DIIIantigen.WNVDIIIorDENV-2DIIIantigenproducedinE.coli
was immobilized on an ELISA plate and incubated with increasing
concentrations of lettuce or N. benthamiana-derived E16 mAb
(L-E16 or B-E16), mammalian cell-derived E16 (M-E16, positive
control), or a negative control generic human IgG (NC). A HRP-
conjugated anti-human IgG was used to detect mAbs bound to DIII
antigens.Mean ±SDofOD450 fromthreeindependentexperiments
are presented.
the absorbance of the WNRA and the NCA is above a preset
threshold. In our modiﬁed ELISA, plant-derived E16 was
conjugated to HRP ﬁrst and then used to replace the WNRA-
speciﬁc antibody in the original kit. Accordingly, WNRA was
replaced by our plant-derived DIII antigen in the modiﬁed
assay. Our results showed that the plant-derived DIII antigen
and E16 mAb eﬀectively diﬀerentiated the WNV human
IgM-positive serum from the negative control serum in
a similar manner as the reagents in the commercial kit
(Figure 6). The ISRs of our modiﬁed assay for the negative
control serum are 1.09 (lettuce-derived E16) and 1.24 (N.
benthamiana-E16), which are similar to that of the original
assay (1.61) and well within the required ISR range (<4.47).
Similarly, ISR for the WNV IgM-positive serum is compa-
rable between the modiﬁed and original assay (8.68 and 8.98
versus 13.48), which are also within the required speciﬁca-
tion range (>5.66). The positive IgM control serum showed
a lower absorbance in the plant-derived DIII/E16 samples
than that of WNRA/anti-WNRA (Figure 6). Since both
WNRA and plant-produced DIII were added to the reaction
in concentrations high enough to saturate all binding sites
of WNV-speciﬁc IgMs that were captured on the plate by
anti-IgM antibodies, it is unlikely that this is caused by the
concentration diﬀerence of the two antigens. Instead, the
potential diﬀerence in antigen-binding site and/or valency
between the reference standard mAb and plant-derived E16
mAb is a more likely factor in causing the observed diﬀer-
ence. It also remains possible that this result corroborates
the previous observation that WMV DIII-speciﬁc IgM titers
in the sera of infected mammals are generally lower than
those of WNV E protein [29]. We are currently expressing
a full-length WNV E protein in plants to address this
issue. Nonetheless, this example clearly demonstrated the
eﬀectiveness of plant-derived antigen and mAb as reagents
for detection and diagnosis of WNV infection and suggested
their potential applications in other diagnostic assays.
4. Discussion
The rapidity of the spread of WNV and the potential threat
tobird,mammal,andhumanpopulationsdemandthedevel-
opment of a technology platform that can rapidly produce a
variety of protein reagents, ﬂexibly and at low cost, to sup-
port the need of detection and diagnosis suﬃcient to address
the potential public health crisis. Here, we investigated the
feasibility of using plants to produce a WNV antigen and a
mAb against WNV to address the cost and scalability issues
associated with mouse hybridoma mammalian, insect, or
bacterial cell cultures. Our results demonstrated that WNV
DIII antigen and E16 mAb can be rapidly produced at high
levels in two host plant species. Furthermore, these proteins
can be easily isolated to high purity with simple extraction
and puriﬁcation methods and they retain the functionality
and speciﬁcity of their original counterparts.
Plants are suitable for antigen and mAb production
because they can produce large volumes of protein at low
cost and be rapidly scaled up for commercial production
without the high-capital investment associated with bioreac-
tor facilities for mammalian, insect, or bacterial cell cultures
[14, 15, 31, 32]. The WNV E glycoprotein is essential for
membrane fusion and mediates binding to cellular receptors,
and is a major target of host antibody responses [33]. DIII of
WNVEproteincontainsthecellularreceptor-bindingmotifs
and the majority of the neutralizing epitopes that induce
strong host antibody responses and/or protective immunity
[13]. As a result, E protein and DIII have been extensively
explored as WNV vaccine candidates and as detection and
diagnostic reagents [7]. The WNV DIII protein has been
produced in insect cell and bacterial cultures [11, 12]. These
culture systems are diﬃcult to scale up for large-scale protein
production. In addition, production of recombinant DIII in
bacterial cultures requires a cumbersome solubilization and
refolding process due to the formation of inclusion bodies
[11]. In contrast, DIII antigen was expressed rapidly in N.
benthamiana plant as a soluble protein and accumulated to
1% of TSP or 0.1mg/g FLW, the highest expression level of
any ﬂavivirus antigen ever reported in plants. In addition,
plant-derived DIII can be easily puriﬁed to >95% purity
without the needs of solubilization and refolding.
We previously investigated the possibility of producing
E16 as a post-exposure therapeutic mAb in N. benthamiana
with the TMV and PVX-based MagnICON system. In that
investigation, the “KDEL” tetrapeptide ER-retention signal
was added to the C-terminus of the HC [23], and/or E16
was expressed in “humanized” plant lines that can addJournal of Biomedicine and Biotechnology 7
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Figure 5: Identiﬁcation of WNV E protein displayed on the cell surface of yeast by plant-derived E16 mAbs. Lettuce (L-E16) or N.
benthamiana-produced E16 mAb (B-E16), mammalian cell-derived E16 (M-E16, positive control), or a generic human IgG (NC, negative
control) was used to stain yeast cells displaying WNV E protein, which were then processed by ﬂow cytometry. Representative data from
three independent experiments are shown.
mammalian glycoforms to mAbs (Q. Chen, unpublished
results). These extra procedures were performed to avoid the
production of plant-speciﬁc glycans, which may trigger a po-
tentially harmful immune response in human patients. Since
diagnostic reagents are used in vitro, the concern for the
potential adverse host immune response becomes irrelevant.
Thus, in this study we examined the feasibility of using wild-
type plants and HC without the extra-KDEL ER-retention
peptide to produce E16. Furthermore, instead of using the
MagnICON system of the previous study, we tested the
ability of geminiviral replicon vectors for E16 production
because it can direct recombinant protein expression in both
tobacco and lettuce [24]. Our results showed that the KDEL-
lessE16canbeproducedinwild-typeplantswithgeminiviral
vectors and accumulated to a level comparable to the highest
expression level for mAbs in plants ever reported. The ease
of using wild-type plants to produce E16 not only simpliﬁes
the experimental procedure, but also minimizes biosafety
and regulatory concerns and costs associated with transgenic
cropsandgeneticallymodiﬁedplants[15].Furthermore,E16
mAbs produced from both wild-type N. benthamiana and
lettuce can be easily puriﬁed to >95% purity and retain their
highly-speciﬁc antigen binding avidity.
In addition to wild-type N. benthamiana, we also ex-
plored the possibility of using laboratory-grown lettuce to
produce E16. Similar to N. benthamiana,l e t t u c ei sar o b u s t -
growing plant that produces large quantities of biomass
rapidly. In contrast to tobacco, it produces negligible quan-
tities of phenolics and alkaloids and, thus, can potentially
simplify the protein puriﬁcation process and reduce the
overall cost of goods in commercial production. Our results
demonstratedthatlettuce-producedE16mAbhasequivalent
structure and functionality as N. benthamiana-derived E16.
Previously we showed that mAbs can be expressed in grocery
store-bought lettuce [24]. This potentially would allow
us to have access to unlimited quantities of inexpensive
plant material for the large-scale commercial production
of E16 as a detection and diagnostic reagent. Overall, the
capability of performing posttranslational modiﬁcations by
plant cells and the availability of the glycoengineered plant
lines to produce recombinant proteins with mammalian
glycoforms provide our plant system the advantage over
bacterial cultures in producing mAbs and antigens that
require posttranslational modiﬁcation. Moreover, the rapid
high-level production and assembly of E16 and a simple
current good manufacture-practice- (cGMP-) compliant8 Journal of Biomedicine and Biotechnology
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Figure 6: WNV IgM capture ELISA with plant-derived DIII
antigen and E16 mAbs. Columns 1 and 2 (positive controls): WNV
IgM-positive serum (PC) detected by kit-supplied positive control
antigen WNRA (1) or negative control antigen NCA (2) with the
kit-supplied WNRA-speciﬁc antibody (Anti-WNRA); Columns 3
and 4 (negative controls): WNV IgM negative serum (NC) detected
by WNRA (3) or NCA (4) with Anti-WNRA; Columns 5 and 6:
PC detected by N. benthamiana-derived DIII antigen (B-DIII) (5)
or NCA (6) with lettuce-derived E16 (L-E16); Columns 7 and 8:
N Cd e t e c t e db yB - D I I I( 7 )o rN C A( 8 )w i t hL - E 1 6 ;C o l u m n s9a n d
10: PC detected by B-DIII (9) or NCA (10) with N. benthamiana-
derived E16 (B-E16); Columns 11 and 12: NC detected by B-DIII
(11) or NCA (12) with B-E16.
puriﬁcationscheme—convincinglydemonstratetheviability
of this system for large-scale cost-eﬀective production of
mAbs compared to hybridoma and mammalian cell cultures.
We further demonstrated the utility of plant-derived an-
tigen and mAbs in detection of WNV or host immune re-
sponses to WNV infection in a ﬂow-cytometry-based and
a WNV IgM capture ELISA assay. The results of these
examples clearly indicated their value in the detection
of WNV and diagnosis of WNV infection and suggest
their potential application in other protein-based assays.
One critical issue of immunobased WNV diagnosis is the
cross-reactivity of antibodies among ﬂaviviruses. The high
speciﬁcity of plant-derived E16s may provide us a valuable
toolinaddressingsuchproblems.Forexample,plantE16can
beusedinaVecTest-likeWNVantigenassaytorapidlydetect
WNV infection in wild bird and mosquito populations [34].
Since plant E16 does not recognize DIII protein from other
ﬂaviviruses, this high speciﬁcity will improve the accuracy
of the current assay and reduce ambiguity. Sotelo and
colleagues have recently developed a new epitope-blocking
ELISAthathasdemonstratedutilityindetectingWNVinfec-
tion in a wide range of hosts, including humans, birds, and
othermammals[35].ThisELISAutilizesamousehybridoma
cell-derivedneutralizingmAbthatbindsWNVEproteinand
requires very small volumes of sera, making it feasible to
directly test small-size birds and mammals without harming
their health. As a result, this new method promises to be
helpful for both disease diagnosis and surveillance. Since
plant-derived E16 is a neutralizing mAb that binds to WNV
E protein, we speculate that its high speciﬁcity to WNV DIII
will enhance the speciﬁcity of this assay. In addition, using
plant-derived E16 for this assay will address the issue of
production scalability of mouse hybridoma cells and greatly
reduce the cost of mAb production.
The research of our laboratory and others has demon-
strated the ability of plants in producing a variety of recom-
binant proteins at low cost [15, 31, 32, 36, 37]. This study
extends the utility of plant expression system to the pro-
duction of mAbs and antigens as detection and diagnostic
reagents for arboviruses. One of the concerns of plant bio-
technology has been whether the product yield can be high
enough to allow large-scale production and advance the
technology beyond the proof-of-principle stage. While this
was a valid issue for traditional plant expression systems, the
high-levelproductyieldofnewplantexpressionsystemshave
suggested that such concern is no longer necessary. These
new expression systems such as the MagnICON and gem-
iniviral expression systems used in this study have allowed
high and consistent level of target protein accumulation in
plants suﬃcient for commercial-scale manufacturing [14,
15, 21]. For example, several of pharmaceutical proteins
produced by these plant expression systems with similar
product yield as WNV DIII and E16 mAb have not only been
produced on a large scale under the United States Food and
DrugAdministration’s(FDA)cGMPregulationbutalsohave
been tested in late-stage human clinical trials [14, 15, 38].
The high-level product yield of DIII antigen and E16 mAb
and their simple cGMP-compliant puriﬁcation schemes,
demonstrate the viability of our plant production system
for their large-scale cost-eﬀective production and suggest a
promising future beyond the proof-of-principle stage.
In addition to promoting high product yield, one of
the other advantages of plant-transient expression systems
is the rapid speed of target protein production [17]. With
both MagnICON and geminiviral expression systems, our
antigen and mAbs were produced within a week of vector
inﬁltration. These rapid and high protein accumulation
levels provide the ﬂexibility and versatility of the plant
production system that are superior over other production
systems in accommodating the demands of new reagents by
the fast-evolving diagnostic assays. For example, if a novel
assay has been approved for viral detection and diagnosis,
the plant-transient expression system canbe rapidly adjusted
to produce the new reagents within one to two months.
This ﬂexibility and versatility also give the plant production
systemanadvantageinproducingavirtuallyunlimitednum-
ber of protein detection and diagnostic reagents for not only
WNV but for many other arboviruses, such as dengue virus,
Japanese encephalitis virus, St. Louis encephalitis virus, and
yellow fever virus.
5. Conclusions
This research demonstrated the eﬀective production of
functional protein reagents in plants for the detection of
WNV and diagnosis of WNV infection. The robustness,
cost eﬀectiveness, scalability, and ﬂexibility of the plantJournal of Biomedicine and Biotechnology 9
system will make it an attractive platform for the production
of detection and diagnostic reagents for a broad range of
arboviruses.
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